Co-Diagnostics, Inc. Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Co-Diagnostics, Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2026-06-30 was $213.75K, a 63.16% decline year-over-year.
- Co-Diagnostics, Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2026-03-31 was $219.11K, a 74.96% decline year-over-year.
- Co-Diagnostics, Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-09-30 was $500.58K, a 52.12% decline year-over-year.
- Co-Diagnostics, Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-06-30 was $580.26K, a 61.31% decline year-over-year.
- Co-Diagnostics, Inc. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2025 was $2.25M, a 58.64% decline from fiscal 2024.
- Co-Diagnostics, Inc. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2024 was $5.43M, a 34.81% decline from fiscal 2023.
- Co-Diagnostics, Inc. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2023 was $8.34M, a 10.52% increase from fiscal 2022.
- Co-Diagnostics, Inc. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2022 was $7.54M, a 36.92% increase from fiscal 2021.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2026-06-30 | $213.75K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $219.11K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $2.25M 10-K · filed 2026-03-31 | |
| 2025-09-30 | $500.58K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $580.26K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $875.23K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $5.43M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $1.05M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $1.50M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $1.57M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $8.34M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $2.17M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $2.17M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $2.17M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $7.54M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $2.23M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $1.53M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $1.38M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $5.51M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $1.41M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $927.34K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $1.51M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $2.74M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $1.04M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $691.42K 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $432.82K 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $1.09M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $275.95K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $505.97K 10-Q · filed 2020-11-16 | |
| 2019-03-31 | $87.79K 10-Q · filed 2020-11-16 | |
| 2018-12-31 | $1.33M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $525.38K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $50.00K 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $2.03M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |